Nice

News

NICE recommends Celgene's Ozanimod to treat ulcerative colit...

The new treatment with ozanimod (also known as zeposia) will benefit over 12,000 adults who suffer from moderate to severe active ulcerative colitis (UC).

News

NICE says no to Lynparza in prostate cancer, creates UK acce...

NICE has said it is unable to recommend NHS use of AstraZeneca's Lynparza for some patients with prostate cancer, after failing to reach an agreement on price with the drugmaker.

News

CSL Vifor plans UK launch after NICE backs rare disease drug...

UK cost-effectiveness organisation NICE has recommended routine NHS use of a recently-approved therapy for two forms of ANCA-associated vasculitis (AAV) – oral complement C5 inhibitor Tavne

Market Access

Business women studying charts and diagrams on digital tablet closeup. Business meetings concept

UK life science competitiveness indicators 2022: measuring w...

The latest life science competitiveness indicators (LSCIs

News

NICE backs AliveCor's smartphone-linked ECG for NHS use

In draft guidance, NICE has said that AliveCor's ECG recording device should be an option to check or heart disturbances in patients who take antipsychotic medicines.

Oncology